Julie M. Cherrington

Julie M. Cherrington (board member) discloses dealings in 2 companies, chiefly Mirati Therapeutics, Inc. and Vaxart, Inc. We count 12 filings; the first trade dates from 3 January 2020 and the latest from 23 January 2024.

Every open-market trade on record is a sale: 4 sales worth €590k. Outside the open market, there are 6 share grants.

Most recently, on 23 January 2024, the filings show a transaction in Mirati Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.